Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

“…<b>a. RT-qPCR analysis:</b> relative TMPRSS2-ERG fusion variants III and IV mRNA levels were analysed and compared to non-treated cells. …”

Validation of RNA-sequencing by Q-PCR and effects of 5Aza-dC on a subset of DM and DE genes in CESC and OESC. by Iveta Yotova (451965)

“…<b>A)</b> The relative expression of <i>SLC22A23</i> under treatment with 5aza-dC increases in CESC as well as in OESC. …”

Chemotherapy decreases cell proliferation in the adult mouse CNS by Joerg Dietrich (35101)

NS4B decreases TRIF protein level. by Yisha Liang (5244368)

Decreased cell stiffness after dissociation of intercellular adhesion. by Kristina Seiffert-Sinha (627059)

“…The corresponding cross section height measurements show a height decrease by slightly less than 100 nm (from ∼10 nm to −100 nm in the encircled area; lower panel); the arrow in the AFM images points to an intact intercellular connection before cutting (<b>E1</b>) and the disappearance thereof after cutting (<b>E2</b>). …”

HFD induces LDs and decreases ER and mitochondria in nephrocytes. by Aleksandra Lubojemska (10746241)

“…(<b>E</b>) Low and high magnification views of pericardial nephrocytes (dotted outlines) from STD and HFD larvae, showing that HFD decreases mitochondria (marked with anti-ATP5A) and ER (marked with anti-KDEL) but increases LDs (marked with LipidTOX). …”

HCV infection decreases MIN6 cell viability. by Qian Wang (32718)

Comparing the product effect on changes in body weight of all groups before and after feeding, g. by Fatima Dikhanbayeva (11501962)

Subjects:

The results of assay of blood serum biochemical parameters after experiment. by Fatima Dikhanbayeva (11501962)

Subjects:

Schematic representation of possible mechanism of action of OKN-007 in IC3752 pGBM tumor bearing mice. by Patricia Coutinho de Souza (780490)

“…By removing 6-O-sulfates on HS chains and mobilizing protein ligands from HSPG sequestration in the extracellular environment (3), the SULF-2 can increase the solubility of a variety of growth factors (e.g. PDGF) (4) thus increasing the activation of PDGFR-α and downstream signaling pathways in tumor cells (5) [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0134276#pone.0134276.ref098" target="_blank">98</a>]. …”

The substitution F447L is adaptive for J4_S52-HVR1, while it decreases infectivity of parental J4 and J4_ΔHVR1 HCVcc. by Christina Holmboe Olesen (11154333)

GO treatment decreased SR-B1 levels. by Claudia Sticozzi (329024)

Effect of OKN-007 on the immunoexpression of decorin in IC3752 pGBM tumor bearing mice. by Patricia Coutinho de Souza (780490)

Dcp1a protein levels are decreased by KapB expression and Torin treatment. by Carolyn-Ann Robinson (13297009)

Effect of OKN-007 on diffusion measured as ADC values in IC3752 pGBM tumor bearing mice. by Patricia Coutinho de Souza (780490)

Brain metabolite ratios in normal and untreated vs. OKN-007 treated IC3752 pGBM tumor bearing mice. by Patricia Coutinho de Souza (780490)

Effect of OKN-007 on perfusion rates measured as rCBF in IC3752 pGBM tumor bearing mice. by Patricia Coutinho de Souza (780490)

Results of peptide toxicity of each diet. by Fatima Dikhanbayeva (11501962)

Subjects:

Pharmacological Mechanism of the Non-hallucinogenic 5‑HT_2A Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

“…Ariadne is a non-hallucinogenic analog in the phenylalkylamine chemical class of psychedelics that is closely related to an established synthetic hallucinogen, 2,5-dimethoxy-4-methyl-amphetamine (DOM), differing only by one methylene group in the α-position to the amine. …”

Pharmacological Mechanism of the Non-hallucinogenic 5‑HT_2A Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

“…Ariadne is a non-hallucinogenic analog in the phenylalkylamine chemical class of psychedelics that is closely related to an established synthetic hallucinogen, 2,5-dimethoxy-4-methyl-amphetamine (DOM), differing only by one methylene group in the α-position to the amine. …”